Clinical Evaluation of Florbetapir in Primary Progressive Aphasia

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 15, 2012

Primary Completion Date

September 2, 2015

Study Completion Date

February 28, 2017

Conditions

Primary Progressive AphasiaAlzheimer DiseaseDementia

Interventions

DRUG

Florbetapir F 18

A single injection of 10 mCi (370 MBq) florbetapir F 18 will be administered by intravenous bolus injection.

DEVICE

Positron Emission Tomography

PET Scan for brain imaging

Trial Locations (1)

The Healthy Aging & Alzheimer's Research Care Center - University of Chicago, Chicago

All Listed Sponsors

lead

University of Chicago

OTHER

NCT04726527 - Clinical Evaluation of Florbetapir in Primary Progressive Aphasia | Biotech Hunter | Biotech Hunter